Recently the identity of the PLC that is coupled to AT, receptors has come into question Marrero et ali2 showed that m VSMCs, ang II phosphorylates PLC-y and that mcubation of cells with the tyrosme kmase inhibitor gemstem nearly abolishes mositol trisphosphate formation These results suggest that the AT, receptor is coupled to PLC-7 via a tyrosme phosphorylation mechamsm However, other data support the concept that ang II receptors are coupled to a G protein-linked PLC Thus, in permeabihzed VSMCs, GTPyS synergistically enhances ang IIInduced mositol trtsphosphate generation I1 Furthermore, downregulation of Go,,, , by prolonged agonist incubation markedly abrogates the abiltty of ang II to stimulate PLC,l4 implying that a G protein of the Gq family is mvolved m couphng the AT, receptor to PLC It is possible that a G protein-coupled tyrosme kmase is upstream of PLC-y, but it is also possible that another PLC isotype is involved The identity of this putative G protein-coupled PLC IS unclear, smce the prototypical subtype, PLC-,O, is not found in VSMCs 12 A leading candidate is PLC-6, which IS robustly expressed in vascular tissue 1s
Ang II also activates PLD, hydrolyzmg phosphatidylcholine to choline and phosphatidtc acid In VSMCs, phosphatidic acid is rapidly converted to diacylglycerol by phosphatidic acid phosphohydrolase PLD acttvatton IS subsequent to that of PLC it is detectable at 1 to 2 minutes and remains elevated for as long as 1 hour 16 In contrast to the PLC response, PLD activation does not appear to desensitize sigmficantly during this time period This pathway is the most important source of phosphatidic acid and dtacylglycerol and probably represents the major pathway by which protein kmase C remains activated There are two major unresolved questions concerning the AT, receptor and the PLD pathway First, the mechanism by which the receptor couples to PLD is unknown Smallmolecular-weight G proteins (arf, rho), pertussis toxmsensitive and -1nsensittve heterotrimertc G proteins, pro-
Selected Abbreviations and Acronyms
Ang II = anglotensm II AT, = anglotensm type I receptor GRK(s) = G protemxoupled receptor kmase(s) MAP = mltogen-activated protem PLA,, PLC, PLD = phosphohpases A*, C, D VSMC(s) = vascular smooth muscle cell (s) tem kmase C actrvatron, and tyrosme phosphorylatron have been variously suggested as couplmg mechamsms 17 Recent data indicate that there 1s a famtly of PLD tsoforms, 18 which may explain the plethora of proposed coupling mechanisms Our own data m VSMCs strongly suggest that a heterotrrmerrc G protein 1s mvolved (K K G et al, unpublished data, 1997) , although the rdentrty of the G protein and even the responsible subunit remains to be determined The second major issue concernmg PLD 1s its function in VSMCs. It 1s without doubt the major source of dracylglycerol for actrvatron of protein kmase C, 16 but rt 1s likely to have other functions as well For growth factors such as platelet-derived growth factor, rt has been suggested that PLD 1s integral to the growth response.19
In neutrophrls, the phosphatrdrc acid that results from PLD serves to activate an NADPH oxrdase 20 Although a srmliar oxrdase 1s activated by ang II in VSMCs,*r a role for PLD in this response remains to be established. In addrtron to PLC and PLD, ang II rapidly activates PLA2 to release free fatty acids such as arachrdonate 22 PLA2 activity m response to ang II 1s evrdent wrthm minutes and is sustained for at least 30 minutes The arachrdomc acid that 1s produced 1s then converted via cyclooxygenase to prostaglandms, via hpoxygenase to unstable hydroperoxy intermediates that go on to form the leukotrrenes, hydroxyercosatetraenorc acids and hpoxms, or via cytochrome P450 monooxygenase to epoxrdes, mrdchain cishrans conjugated drenols, and C-19/C-20 alcohols Natarajan et al*3 have shown that the hpoxygenase pathway has a role m VSMC hypertrophy In addition, our recent data suggest that arachrdomc acid metabohtes may be involved in activation of NADH/NADPH oxrdase (see below), thus regulating the oxrdatrve state of the cell 24
Tyrosine Phosphorylation
Recently tt has become apparent that ang II, like many growth factors, stimulates the phosphorylatron of numerous proteins on tyrosme residues (Table) . Several of these proteins have been identified, and rt 1s clear that phosphorylatron and dephosphorylatron of specific tyrosmecontaining proteins are important signaling events. In one of the earliest reports of ang II-induced tyrosme phosphorylatron m VSMCs, Tsuda et al*5 demonstrated that at least nine proteins are phosphorylated by ang II on tyrosme This phosphorylatron was mrmrcked either by phorbol 1Zmyrrstate 13-acetate actrvatron of protein kmase C or by addmon of the calcmm ronophore ronomycm, suggesting that tyrosme kmase actrvatton 1s downstream of PLC and PLD Subsequent reports have identified numerous additional proteins phosphorylated on tyrosme by ang II in both VSMCs and cardiac fibroblasts 12.25-32
Several of these tyrosme-phosphorylated proteins deserve specific comment Ang II has been shown to phos- 
MAP Kinase Pathway
MAP kmases comprise a superfarmly of serme/threonme protein kmases involved in cell growth and differentiation, as well as in cell transformation.42 ERKl (~44~~~~) and ERK2 (p42""pk), the most well studied of the MAP lunases, are activated by dual phosphorylation on the threomne and tyrosme occurrmg in the motif TEY43 and m turn phosphorylate numerous cellular proteins, mcludmg MBP, pp90rSk, p62TCF, 4E-BP-l, cPLA2, c-Jun, and PHAS-1 44 Since the mltlal ldentlficatlon of ERKl and ERK2, several other members of the MAP kmase superfamily have been identified, including ERK3 lsoforms, Jun N-terminal kmases/stress-activated protem kmases (JNWSAPK), p3gmpk, p57 mapk, and BMK-1 (Big MAP kinase-1 or ERKS).
It is now well documented that ang II activates the MAP kmase pathway m VSMCs ERKI and ERK2 were among the first tyrosme-phosphorylated proteins to be identified m ang II-stimulated cells 25.29.45,46 MAP kmase actlvatlon by ang II in VSMCs appears to be transient with a peak around 2 to 5 minutes, although activity remains elevated above baseline for at least 60 mmutes.45-47 Stlmulatlon of MAP kinase 1s at least partially dependent on protein lunase C45 and apparently requires prior activation of a Ca*+-dependent tyrosme kmase 47
Recent work has focused on the blochemlcal pathways leading to MAP kmase activation (Fig 2) The immediate activator of MAP kmase 1s MEK (MAP or ERK kmase), which 1s a dual-specificity kmase that phosphorylates ERKl and ERK2 on both threomne and tyrosme 48 MEK in turn 1s activated when it 1s phosphorylated on serme by a MAP kmase kmase At least three MAP kmase kmases have been identified, raf-1, c-mos, and MEK kinase,49 two of which (raf-1 and MEK kmase) are activated by ang II.29350 raf-1 1s stimulated by phosphorylatlon on threomne and serme and is recruited to the plasma membrane by the small-molecular-weight G-binding protein ras 51 It is at this point that our knowledge of the MAP kinase activation pathway becomes sketchy The stimulation of ras by growth factor receptors is complex, involving receptor autophosphorylatlon and bmdmg to the SH2 domain of the adaptor protein Grb2, which then bmds to the guanme nucleotlde exchange factor SOS via its SH3 domain 52 A slmliar pathway may be used by G protein-coupled receptors, except that the initial tyrosme kmase 1s a nonreceptor tyrosme kmase This has been clearly shown for Gl-coupled receptors,53 and evidence 1s accumulating that some Gqcoupled receptors may utlhze this pathway as well 54 The most proximal kmase activated by these receptors 1s unknown, but current data suggest that a member of the src kmase family, src itself, lyn, or syk, may be mvolved 54 It has also been postulated that PI3 kmase activation may be upstream of ras activation 55 The primary signal mltlatmg this cascade has been proposed to mvolve a Ca*+-dependent protein kmase47 or the Pr subumts of a coupling G protein 37 With regard to this pathway, ang II has been shown to activate pp60 , ST' ** to promote assoclatlon of Grb and SOS,27 to activate ras,47 and to phosphorylate raf-129 and MEK,50 although the links between each of these events remam to be established As noted above, MAP kmase activity m response to ang Il 1s transient, raising the Issue of the mechamsm(s) responsible for signal termmatlon. Inactivation appears to be achieved by dephosphorylatlon of MAP kmase The phosphatase responsible for this event, MKP-1 (nutogen-activated protein kmase phosphatase-1), was ongmally isolated as a nonspecific tyrosme phosphatase (3CH134) and was subsequently shown to have hgh specificity for MAP kmase.56 Like MEK, MKP-1 has dual specificity. It dephosphorylates MAP kmase on both threomne and tyrosine.56 In VSMCs, mtibltlon of MKP-1 leads to sustained activation of MAP kinase m response to ang II, suggesting that it 1s this enzyme that 1s pnmanly responsible for the termmatlon of the MAP kmase signal 57 MKP-1 expression m turn 1s stimulated by ang II, so that MKP-1 serves as a long-term negatlve-feedback regulator of this pathway. It is somewhat paradoxical that the most intense focus on ATIA receptor coupling mechamsms m VSMCs has been on PLC acttvatron, a response that, regardless of the rsozyme involved, is markedly desensmzed and attenuated m ~5 minutes. In contrast, ang II-stimulated PLD is robustly activated as long as it has been followed to date-=I hour The mechanisms responsible for this selective desensmzation to PLC are not entirely understood. Desensitization to PLC prominently and perhaps predominantly mvolves protein kmase C, since downregulation of protein kmase C results in prolonged strmulatron of PLC.61 In contrast, PLD activity cannot be sustained m the absence of protein kinase C activation (K.K.G. et al, unpublished observations, 1997). Termination of the PLC response may also involve phosphorylatron of the receptor by GRKs, which in the P-adrenergic receptor system phosphorylate hgand-bound receptors, promotmg the bmdmg of arrestm and the consequent mterruptton of G protein-mediated signal transduction 62 The ATi* receptor has been shown to be phosphorylated on serme and tyrosine in response to ang II, with a peak at 20 minutes of ang II stimulation 63 Although the kmases responsible for this phosphorylation m vlvo are not known, m HEK293 cells cotransfected with the ATi* receptor and GRK-2, -3, or -5, receptor phosphorylation is augmented. 64 Overexpressron of a dominant negative K220R mutant GRK2 and inhrbition of protein kmase C both attenuated, in an additive fashion, ang IIinduced ATi* receptor phosphorylation,a suggesting that not only are GRKs involved m receptor phosphorylation but that receptor phosphorylation may also be an additional mechanism by which protein kinase C desenstttzes PLC. In contrast, PLD is stimulated by exogenous activators of protein kmase C, and signaling through the PLD pathway in response to ang II continues even when the receptor is phosphorylated 16.63 These observations suggest that the two responses, PLC and PLD, are independently regulated and that PLD activation is resistant to conventional mechanisms of desensitization A recent hypothesis developed to explain these dlsparate signaling events mvolves the creation of stgnalmg domams by ang II. It has long been known that the ang II receptor internalizes rapidly upon binding of the hgand.65*66 In fact, rt was origmally proposed as a mechanism of desensttrzatron. However, the AT, receptor mternahzes with a half-time of 1 5 minutes,@ whereas PLD signaling commences at about this time and contmues for 1 hour 16 This simple observatron has led to the proposal that the receptor moves withm the plane of the membrane (Fig 3) to a specrahzed domain from which prolonged stgnals are generated. Anderson et a167 showed that AT, receptors rapidly move to coated pits, which internalize as vesicles and fuse with lysosomes. Zhang et al6* found that ATI receptors also move to noncoated pits, suggesting that there may be two internahzation mechanisms. The recent tdentrfication of caveolae as membrane slgnahng domains associated with growth factor receptors69 raises the possibility that the noncoated pit regions in which AT, receptors aggregate may represent srmrlar srgnahng domains. This is a particularly attractive notion, m view of the apparent assoctatron of src with caveolae70 and the recent observation that AT, receptors activate src.28
Long-term Signaling Events: Modulation of the Oxidative State
Although much emphasis has been placed on the rapid, transient biochemtcal pathways stimulated by ang II, it is clear that ang II has prolonged effects on VSMCs As mentioned previously, one of these is PLD, which remains In ang II-stimulated cells, fluorescence has moved to the perinuclear region and has become concentrated in punctate regions on the edges of the cells. activated for as long as the agonist is present.16 Another important tonic signaling pathway is activation of NADWNADPH oxidase (Fig 4) . This enzyme transfers electrons from NADH or NADPH to molecular oxygen, producing superoxide anion (. 0,J. Ang II activation of the NADH/NADPH oxidase is delayed: It is first detectable after about 1 hour and is sustained for at least 24 hours.21 Importantly, when NADH/NADPH oxidase activity is inhibited, ang II-stimulated protein synthesis is also inhibited, implying that activation of this pathway is integral to the growth response.
The structure and activation mechanisms of the VSMC NADH/NADPH oxidase are unknown. Recent work suggests that ang II-stimulated production of arachidonic acid metabolites may be required for oxidase activation, although this pathway has not been fully elucidated.24 In terms of structure, there is some evidence that this enzyme is similar to the bactericidal neutrophil enzyme, which consists of five subunits: a 22-kD a-subunit (~22"~~~) and a glycosylated 91-kD P-subunit (gp91PhoX), which together compose cytochrome &, the electron transfer element; cytosolic components ~47~~"" and ~67"~"'; and a low-molecular-weight G protein, rat 1 or rat 2.71 We have recently shown that smooth muscle oxidase is a p22phox-based enzyme,72 but the presence of other subunits has not been demonstrated in VSMCs. Although VSMC oxidase shares some similarity to the neutrophil enzyme, it differs in several important aspects. First, vascular oxidase preferentially utilizes NADH rather than NADPH as a substrate for its activity, and its output is much lower than that of phagocytic oxidase.2',73,74 Second, the peak of the absorbance spectrum of the cytochrome component of vascular oxidase is shifted slightly to the left (-5.53 nm).7* Finally, knockout of p22phox in vascular cells does not affect baseline NADH-mediated 02-production -but only attenuates ang II-stimulated oxidase activity,'* suggesting that the p22phox-containing oxidase is an inducible protein that has little constitutive activity in untreated cells.
The 02-that is produced by NADH/NADPH oxidase is presumably rapidly converted by superoxide dismutase to H202. We have recently shown that 4 hours of ang II treatment leads to H202 accumulation in VSMCs and that this H202 is a consequence of activation of the p22phox-based enzyme.72 This is important, because the altered redox state of the cell promotes lipid peroxidation, and both lipid hydroperoxides and H202 increase expression of several growth-related and inflammatory genes and activate intracellular signaling pathways. Of potential importance to the VSMC response to ang II is the activation of PLA2,75 MAP kinases,76 and ras,77 as well as the induction of ~$0~78 and c-jun.79 There is some evidence that this pathway is not involved in ang II stimulation of the MAP kinase pathway,76 but in general, the role of reactive oxygen species in growth-related signal transduction is an unexplored area. It is possible that the redox state of the cell acts as a rheostat to modulate the activation of cellular signaling enzymes, such as protein kinase C and tyrosine kinases, and may also directly alter the activity of transcription factors. That reactive oxygen species have a role in VSMC growth is fairly clear. H202 stimulates VSMC 
